IPO Profiles, August

Ambow Education Co. Ltd.

Beijing, ZF

6-10-6206-8000

www.ambow.com

IPO DETAILS

IPO Date: 8/5/10

Exchange and Ticker: NYSE: AMBO

Filing Range: 10.68M ADS* @ $10.00 to $12.00

Offering Price: $10.00 per ADS*

Close on First Day: $9.25 per ADS*

Offering Size: $106.80M

Shares Outstanding: 71.28M

Underwriters: JP Morgan/ Goldman Sachs (Asia)

Co-managers: Signal Hill Capital Group LLC/ Macquarie Capital Partners LLC

Company Counsel: Maples & Calder

Manager Counsel: Simpson Thacher & Bartlett

Auditor: PricewaterhouseCoopers Zhong

Market Capitalization on 8/31/10: $659.34M

Close price at current month end: $9.10 per ADS*

Total VC Raised: $10M+

*Each ADS is equal to 2 ordinary shares.

COMPANY DESCRIPTION

Provides education and training services in China. The company’s services include an online learning platform, system administration tools, education content and offline support services. Ambow Learning Centers offers after-school tutoring programs, university entrance exam preparation, job-readiness training and corporate training. Competitors include Tangram, Founder Cyber Education.

VENTURE BACKERS

Actis Capital, Avenue Capital Group, CID Capital, Cisco Systems, JAFCO Investment, Macquarie Direct Investment Ltd.

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/5/10_Value of shares on 8/31/10*_Percentage ownership post offering

Actis Capital LLP_12,972,159_$59.02M_9.10%

Macquarie Direct Investment Ltd._11,563,026_$52.61M_8.10%

CID Capital¬_10,500,775¬_$47.78M_4.40%

JAFCO Investment_5,357,142_$24.37M_2.60%

*Each ADS is worth 2 ordinary shares, so share value is equal to total ordinary shares multiplied by $4.55 on 8/31/10.

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

04/01/2006_3_$10.00M_n/a

10/09/2007_4_n/a_n/a

09/29/2008_3_n/a_n/a

FINANCIALS

12/31/2007_12/31/2008_12/31/2009

Total Revenue $M: n/a_n/a_$132.15

Net Income $M: n/a_n/a_$20.22

EPS: n/a_n/a_$-0.42

Source: Thomson Reuters and company prospectus

Kanghui Medical Innovation Co. Ltd.

Changzhou, ZF

86-519-85195556

www.kanghui.com

IPO DETAILS

IPO Date: 8/11/10

Exchange and Ticker: NYSE: KH

Filing Range: 5.34M ADS* @ $9.25 to $11.25

Offering Price: $10.25 per ADS*

Close on First Day: $12.16 per ADS*

Offering Size: $68.40M

Shares Outstanding: 21.80M

Underwriters: Morgan Stanley/ Piper Jaffray Inc

Co-managers: Cowen & Co./ Canaccord Genuity

Company Counsel: O’Melveny & Myers

Manager Counsel: Latham & Watkins

Auditor: Ernst & Young LLP

Market Capitalization on 8/31/10: $277.00M

Close price at current month end: $12.72 per ADS

Total VC Raised: $38.99M

*Each ADS represents 6 ordinary shares.

COMPANY DESCRIPTION

The company, also known as China Kanghui Holdings American, develops orthopedic products. The Company is focused on the development of trauma, spine, and joint implants and instruments. Products include drill bits, plates and surgical screws.

VENTURE BACKERS

CDH China Management Co. Ltd., IDG-Accel China Growth Fund, , SIG Asia Investments, Venture TDF Pte Ltd., Vivo Ventures

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/11/10_Value of shares on 8/31/10*_Percentage ownership post offering

IDG-Accel China Growth Fund_21,235,880_$45.02M_16.20%

SIG Asia Investments_18,172,450_$38.52M_13.90%

Venture TDF_12,239,520_$25.95M_9.40%

CDH China Management_8,908,690_$18.89_6.80%

*Each ADS is worth 6 ordinary shares, so share value is equal to total ordinary shares multiplied by $2.12 on 8/31/10

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

02/01/2006_2_$10.00_n/a

01/31/2008_4_$27.00¬_n/a

04/28/2009_1_$1.99_n/a

FINANCIALS

12/31/2007_12/31/2008_12/31/2009

Total Revenue $M: n/a_n/a_$27.00

Net Income $M: n/a_n/a_$10.98

EPS: n/a_n/a_$-0.03

Source: Thomson Reuters and company prospectus

Make My Trip India Pvt. Ltd.

Gurgaon, ZF

91-124-462-8747

www.makemytrip.com

IPO DETAILS

IPO Date: 8/12/10

Exchange and Ticker: Nasdaq: MMYT

Filing Range: 3.85M shares @ $12.00 to $14.00

Offering Price: $14.00

Close on First Day: $26.45

Offering Size: $70.00M

Shares Outstanding: 34,134,002

Underwriters: Morgan Stanley

Co-managers: Oppenheimer & Co. Inc./ Pacific Crest Securities Inc.

Company Counsel: Latham & Watkins

Manager Counsel: Shearman & Sterling LLP

Auditor: KPMG International

Market Capitalization on 8/31/10: $1,160.00M

Close price at current month end: $34.00

Total VC Raised: $44M

COMPANY DESCRIPTION

The company operates as an online travel company focused on the leisure and small-business traveler going to India. Other services include air tickets, hotel reservations, car and taxi bookings, holiday packages, road-trips, weekend breaks and corporate travel desk services.

VENTURE BACKERS

EVentures India Holdings Private Ltd., Gabriel Venture Partners, Helion Venture Partners, SAIF Partners, Sierra Ventures, Tiger Management

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/12/10_Value of shares on 8/31/10_Percentage ownership post offering

SAIF Partners_15,337,760_$521.48M_43.79%

Tiger Management_3,629,760_$123,41M_12.10%

Helion Venture Partners_3,577,220_$121.62_10.21%

Sierra Ventures_2,384,820_$81.08M_6.81%

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

07/01/2000_1_n/a_n/a

05/26/2005_1_$10. 00_0.00

03/08/2006_2_$6.00_0.00

12/16/2006_3_$12.99_0.00

10/08/2007_4_$15.00¬_0.00

FINANCIALS

03/31/2008_03/31/2009_03/31/2010

Total Revenue $M: $38.33_$68.55_$83.56

Net Income $M: $-18.89_$-7.35_$-6.21

EPS: $-1.08_$-0.42_$-0.35

Source: Thomson Reuters and company prospectus

MediaMind Technologies Inc.

New York, N.Y.

646-202-1320

www.eyeblaster.com

IPO DETAILS

IPO Date: 8/11/10

Exchange and Ticker: Nasdaq: MDMD

Filing Range: 5.00M shares @ $14.00 to $16.00

Offering Price: $11.50

Close on First Day: $11.00

Offering Size: $57.50M

Shares Outstanding: 17,901,592

Underwriters: Deutsche Bank Securities Corp./ JP Morgan

Co-managers: Pacific Crest Securities Inc./ ThinkEquity Partners/ Stifel Nicolaus & Co. Inc.

Company Counsel: Davis Polk & Wardwell

Manager Counsel: White & Case LLP

Auditor: Kost Forer Gabbay & Kasierer

Market Capitalization on 8/31/10: $211.23M

Close price at current month end: $11.80

Total VC Raised: $38M

COMPANY DESCRIPTION

The company provides digital advertising solutions that optimize the use of media, creative and data for enhanced performance. The company’s platform includes display ad serving, search, rich media, video, dynamic ads, mobile and emerging media; providing marketers with a cross-channel view of ad campaigns. Competitors include DoubleClick, Atlas, Zedo, PointRoll, Eyewonder and FlashTalking.

VENTURE BACKERS

Insight Venture Partners

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/11/10_Value of shares on 8/31/10_Percentage ownership post offering

Insight Venture Partners_2,911,000_$34.35M_17.50%

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

12/23/2003_1_$8.00_n/a

03/21/2007_2_$30.00_n/a

FINANCIALS

12/31/2007 12/31/2008 12/31/2009

Total Revenue $M: $44.74_$63.77_$65.08

Net Income $M: $7.36_$6.16_$5.98

EPS: $0.59_$0.86_$0.69

Source: Thomson Reuters

NuPathe Inc.

Conshohocken, Penn.

484-567-0130

www.nupathe.com

IPO DETAILS

IPO Date: 8/6/10

Exchange and Ticker: Nasdaq: PATH

Filing Range: 5.00M shares @ $14.00 to $16.00

Offering Price: $10.00

Close on First Day: $9.61

Offering Size: $50.00M

Shares Outstanding: 14,546,161

Underwriters: Leerink Swann & Co./ Lazard Capital Markets

Co-managers: Needham & Co. LLC

Company Counsel: Morgan Lewis & Bockius

Manager Counsel: Wilmer Cutler & Pickering

Auditor: KPMG LLP

Market Capitalization on 8/31/10: $114.33M

Close price at current month end: $7.86

Total VC Raised: $63.06M

COMPANY DESCRIPTION

The company focuses on the acquisition and development of therapeutic products in the area of neuroscience. NuPathe develops therapeutics for the treatment of neurological and psychiatric disorders including migraine, Parkinson’s disease and schizophrenia.

VENTURE BACKERS

Battelle Ventures, Ben Franklin Technology Partners Southeastern PA, BioAdvance, Birchmere Ventures, Quaker BioVentures, Safeguard Scientifics Inc., S.R. One Ltd.

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/6/10_Value of shares on 8/31/10_Percentage ownership post offering

Quaker BioVentures_2,795,863_$21.97M_19.17%

Safeguard Scientifics_2,298,959_$18.07M_15.78%

Birchmere Ventures_1,195,225_$9.39M_8.21%

Battelle Ventures_1,149,220_$9.03M_7.90%

S.R. One Ltd._924,278_$7.26M_6.35%

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

10/24/2005_2_$0.50_n/a

09/13/2006_7_$15.00_n/a

10/22/2007_2_$1.33_n/a

04/07/2008_2_$0.67_n/a

07/08/2008_8_$35.00_n/a

07/09/2009_2_n/a_n/a

04/23/2010_5_$10.06_n/a

FINANCIALS

12/31/2007 12/31/2008 12/31/2009

Total Revenue $M: $0.00_$0.00_$0.00

Net Income $M: $-9.68_$-17.51_$-15.59

EPS: $-3.67_$-6.49_$-6.28

Source: Thomson Reuters

RealPage Inc.

Carrollton, Texas

972-820-3923

www.realpage.com

IPO DETAILS

IPO Date: 8/12/10

Exchange and Ticker: RP: Nasdaq

Filing Range: 13.50 million shares @ $13.00 to $15.00

Offering Price: $11.00

Close on First Day: $14.52

Offering Size: $135.30M

Shares Outstanding: 62,305,404

Underwriters: Credit Suisse/ Deutsche Bank Securities Corp.

Co-managers: William Blair & Co./ RBC Capital Markets/ JMP Securities LLC/ Pacific Crest Securities Inc.

Company Counsel: Wilson Sonsini Goodrich & Rosati

Manager Counsel: Simpson Thacher & Bartlett

Auditor: Ernst & Young LLP

Market Capitalization on 8/31/10: $1,043.06M

Close price at current month end: $16.74

Total VC Raised: $47.92M

COMPANY DESCRIPTION

Provides Web-based property management systems for property owners. The company’s property management systems streamline site-based business processes such as screening, leasing, and rent management, and automate back-office accounting, portfolio management and revenue management functions.

VENTURE BACKERS

Apax Partners Worldwide Ltd., Camden Partners, Leeds Equity Partners, Seren Capital, Warnock & Co.

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/12/10_Value of shares on 8/31/10_Percentage ownership post offering

Apax Partners Worldwide Ltd._14,934,167_$249.99M_17.80%

Camden Partners Inc._2,677,025_$44.81M_3.40%

Leeds Equity Partners_3,887,733¬_$65.08M_3.10%

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

12/30/2003_1_$20.00_n/a

12/14/2005_2_$6.50_n/a

10/03/2006_1_$1.68_n/a

03/07/2008_3_$11.93_n/a

11/10/2009_3_$3.72_n/a

05/20/2010_1_$0.11_n/a

07/01/2010_3_$3.98_n/a

FINANCIALS

12/31/2007_12/31/2008_12/31/2009

Total Revenue $M: $83.58_$112.57_$140.90

Net Income $M: $-3.14_$-3.21_$28.43

EPS: $-0.45_$-0.38_$0.21

Source: Thomson Reuters

Trius Therapeutics Inc.

San Diego, Calif.

858-452-0370

www.triusrx.com

IPO DETAILS

IPO Date: 8/3/10

Exchange and Ticker: Nasdaq: TSRX

Filing Range: 6.00M shares @ $12.00 to $14.00

Offering Price: $5.00

Close on First Day: $5.00

Offering Size: $50.00M

Shares Outstanding: 23,554,592

Underwriters: Citi

Co-managers: Piper Jaffray Inc./ Canaccord Genuity/ JMP Securities LLC

Company Counsel: Cooley Godward LLP

Manager Counsel: Latham & Watkins

Auditor: Ernst & Young LLP

Market Capitalization on 8/31/10: $94.69M

Close price at current month end: $4.02

Total VC Raised: $47.77M

COMPANY DESCRIPTION

The company is a drug discovery company applying its structure-based drug design technologies to anti-microbial programs. These programs target proteins in validated pathways. Competitors include Abbott Laboratories, Astellas Pharma and Pfizer.

VENTURE BACKERS

InterWest Partners, Kleiner Perkins Caufield & Byers, Prism VentureWorks, Seraphim Partners, Sofinnova Ventures, Tech Coast Angels, Versant Ventures

STOCK HOLDINGS OF VC FUNDS

(For company directors or owners of 5% or more of the company’s shares.)

Owner_No. of shares on 8/3/10_Value of shares on 8/31/10_Percentage ownership post offering

Sofinnova Ventures_1,892,177_$7.60M_15.30%

InterWest Partners_1,576,814_$6.34M_15.10%

Versant Ventures_1,576,814_$6.34M_13.70%

Prism Venture Partners_1,198,378_$4.82M_12.60%

Kleiner Perkins_1,061,860_$4.27_10.20%

VENTURE ROUNDS

Year_No. of Investors_Round Amt. $M_Valuation $M

06/01/2006_2_$0.57_n/a

07/06/2006_2_$0.80_n/a

02/17/2007_5_$13.24_$27.00

11/09/2007_3_$2.66_n/a

03/19/2008_7_$30.50_n/a

11/05/2009_4_n/a_n/a

FINANCIALS

12/31/2007 12/31/2008 12/31/2009

Total Revenue $M: $1.17_$1.33_$5.02

Net Income $M: $-8.75_$-20.79_$-22.68

EPS: $-3.70_$-4.67_$-1.71

Source: Thomson Reuters